prikaz prve stranice dokumenta Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis
  Preuzmi
PDF 1.18 MB
Znanstveni rad - Izvorni znanstveni rad
Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis
Annals of Hematology, 97 (2018), 7; 1293-1294. https://doi.org/10.1007/s00277-018-3294-9
Lucijanić, Marko; Livun, Ana; Tupek, Katarina Marija; Štoos-Veić, Tajana; Pejša, Vlatko; Kušec, Rajko

Citirajte ovaj rad

Lucijanić, M., Livun, A., Tupek, K. M., Štoos Veić, T., Pejša, V. i Kušec, R. (2018). Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis. Annals of Hematology, 97. (7), 1293-1294. doi: 10.1007/s00277-018-3294-9

Lucijanić, Marko, et al. "Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis." Annals of Hematology, vol. 97, br. 7, 2018, str. 1293-1294. https://doi.org/10.1007/s00277-018-3294-9

Lucijanić, Marko, Ana Livun, Katarina Marija Tupek, Tajana Štoos Veić, Vlatko Pejša i Rajko Kušec. "Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis." Annals of Hematology 97, br. 7 (2018): 1293-1294. https://doi.org/10.1007/s00277-018-3294-9

Lucijanić, M., et al. (2018) 'Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis', Annals of Hematology, 97(7), str. 1293-1294. doi: 10.1007/s00277-018-3294-9

Lucijanić M, Livun A, Tupek KM, Štoos Veić T, Pejša V, Kušec R. Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis. Annals of Hematology [Internet]. 07.2018. [pristupljeno 15.04.2024.];97(7):1293-1294. doi: 10.1007/s00277-018-3294-9

M. Lucijanić, A. Livun, K. M. Tupek, T. Štoos Veić, V. Pejša i R. Kušec, "Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis", Annals of Hematology, vol. 97, br. 7, str. 1293-1294, Srpanj 2018. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:406711. [Citirano: 15.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:406711
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis
AutorMarko Lucijanić
AutorAna Livun
AutorKatarina Marija Tupek
AutorTajana Štoos-Veić
AutorVlatko Pejša
AutorRajko Kušec
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaAnnals of Hematology
Brojčani podacivol. 97, br. 7, str. 1293-1294
p-ISSN0939-5555
DOIhttps://doi.org/10.1007/s00277-018-3294-9
URN:NBNurn:nbn:hr:105:406711
Datum objave publikacije2018-07
URL dokumentahttps://doi.org/10.1007/s00277-018-3294-9
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 10:15:37